Thompson Street Capital Partners (TSCP) announces acquisition of BuildClinical by OpenClinica
Acquiring Company
OpenClinica
Acquired Company
BuildClinical
United StatesNew YorkBiotechnologySoftwareHealth CareHealth CareDescription
Thompson Street Capital Partners (TSCP) has announced the acquisition of BuildClinical, the leading patient recruitment solution for academic researchers, by OpenClinica. The combination of OpenClinica and BuildClinical will offer a complete set of solutions for recruitment, consent, enrollment, and data capture for clinical trial patients, marking a significant milestone in the growth and expansion of both companies.
Quick answer
OpenClinica is acquiring BuildClinical, announced December 10, 2024. OpenClinica is based in United States.
- How much did OpenClinica pay for BuildClinical?
- The deal value was not disclosed.
- What does OpenClinica do?
- OpenClinica is a provider of eClinical software solutions and a portfolio company of Thompson Street Capital Partners (TSCP).
- Where are OpenClinica and BuildClinical based?
- OpenClinica is based in United States. BuildClinical is based in New York, New York, United States.
- Who are the decision-makers at OpenClinica?
- Fundz holds 2 contacts at OpenClinica. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Software
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Exicure, Inc. completes acquisition of GPCR Therapeutics USA Inc. to enhance its pipeline for cell and gene therapies (January 22, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
- Anatomage Inc. completes acquisition of BioDigital to expand medical education technology offerings (January 10, 2025)
- Vivo Infusion completes acquisition of Neurology Institute of San Antonio and Vista Infusions to expand infusion services (January 9, 2025)
- FINSIGHT completes acquisition of Credit Flow Research (CFR) to enhance its presence in the US fixed income market (January 6, 2025)
Who to call at OpenClinica, and when
When OpenClinica changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day OpenClinica raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OpenClinica, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OpenClinica. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OpenClinica makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired BuildClinical?
BuildClinical was acquired by OpenClinica, based in United States. The deal was reported on December 10, 2024. OpenClinica is a provider of eClinical software solutions and a portfolio company of Thompson Street Capital Partners (TSCP). OpenClinica is privately held and operates in Biotechnology.
When did OpenClinica acquire BuildClinical?
OpenClinica's acquisition of BuildClinical was reported on December 10, 2024. Thompson Street Capital Partners (TSCP) has announced the acquisition of BuildClinical, the leading patient recruitment solution for academic researchers, by OpenClinica. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does BuildClinical do?
It is privately held, operating in Health Care, and is based in New York.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.